
51 - 200 employees
Founded 2006
🏥 Healthcare
🔧 Hardware
Healthcare • Hardware
Anteris Technologies is a medical technology company focused on developing next-generation transcatheter heart valve solutions to treat aortic stenosis. The company’s lead product, the DurAVR® Transcatheter Heart Valve (THV), is a single-piece, native-shaped biomimetic valve designed to mimic healthy aortic valve physiology and restore laminar flow. Anteris emphasizes science-driven, measurable improvements in cardiac outcomes, citing early clinical and retrospective analyses (EMBARK, EFS, PARADIGM and investigator-led studies) reporting favorable hemodynamics, reduced patient-prosthesis mismatch, and promising short-term safety signals. DurAVR® is currently available for investigational use only while the company pursues regulatory approvals and broader clinical evaluation. Anteris also engages with the medical community through presentations, webinars, and investigator-sponsored research to build clinical evidence for its biomimetic TAVR approach.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 September 28
Professional Education Manager advancing physician education for Anteris Technologies’ biomimetic TAVR valve. Managing speakers, congress programs, curricula, and digital learning across North America and Europe.
🌐 United States, Canada, +5 more countries – Remote
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Manager
👻 Ghost score 10%
🕒 September 1
Senior Clinical Research Scientist leading global studies for Anteris’ biomimetic TAVR heart-valve technologies. Analyzing clinical data and supporting regulatory submissions, publications, and patient-outcome advances.
🕒 September 1
Clinical Specialist supporting TAVR clinical trials for Anteris Technologies’ biomimetic heart valve. Providing procedural expertise, site education, enrollment support, and clinical evidence advancement.
🕒 July 27
Clinical & Regulatory Affairs role at Anteris Technologies, focused on cardiac care innovations. Supporting research, regulatory strategies, and clinical trials for breakthrough therapies.